Shaping The Future Of Novel Therapy Development

Discover the emerging technologies revolutionising the future of novel therapy development.

Targeted therapies, personalised medicine and gene editing hold great promise for the future of novel therapy development, but challenges remain around market access, patient centricity and differentiation.

In this article, Colin Orford, Senior Vice President, Drug Development Services at ICON, shares his insights on the current trends and industry advances, including:

Leveraging synthetic biology
Widening the CGT Remit
Neurological opportunities
Regulatory matters
Planning for novel therapies

Read the Article

Your company email address

Please select your industry: (max 1)

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By completing this form you agree ICON may store and process your personal data as well as contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy. By clicking submit, you consent to allow Citeline to store and process the information submitted to provide you the content requested. They are subject to their Terms and Conditions.

Please complete all required fields to access the content!

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering: